Complications After CT-guided Lung Biopsies at St. Olavs Hospital (KELSO)

April 7, 2026 updated by: St. Olavs Hospital
At St. Olavs Hospital, a prospective collection of data on complications related to CT-guided lung biopsies has been conducted over several years as part of quality control study. The primary aim of this quality control study is to map complications in all patients who have undergone percutaneous CT-guided lung biopsy at St. Olavs Hospital from May 2012 to December 2023.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1200

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

1200

Description

Inclusion Criteria:

  • All patients eligible to a CT-guided needle biopsy of a lung nodule (allcomers)

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CT-guided lung biopsy
All patient with a lung nodule eligible for CT-guided needle biopsy
Procedure: CT-guided needle biopsy of lung nodule
This is a simple needle biopsy of lung nodules guided with CT imaging

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pneumothorax
Time Frame: Patients are assessed with a CT scan 5 minutes after the lung biopsy
The frequency of pneumothorax after lung biopsy
Patients are assessed with a CT scan 5 minutes after the lung biopsy
Lung bleeding
Time Frame: Patiens are assessed with a CT scan 5 minutes after the procedure
How frequent is parenchymal bleeding after lung biopsy
Patiens are assessed with a CT scan 5 minutes after the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors associated with complications after lung biopsy
Time Frame: All patiens are assessed with CT scan 5 minutes after the lung biopsy
Analyse possible factors leading to complications after lung biopsies
All patiens are assessed with CT scan 5 minutes after the lung biopsy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

St. Olavs Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2012

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

April 7, 2026

First Submitted That Met QC Criteria

April 7, 2026

First Posted (Actual)

April 14, 2026

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 7, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 943833

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumothorax Iatrogenic Postprocedural

Clinical Trials on CT-guided needle biopsy of lung nodule

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe